By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Benzodiazepines > Alprazolam > Alprazolam Dosage
Benzodiazepines
https://themeditary.com/dosage-information/alprazolam-dosage-36.html

Alprazolam Dosage

Drug Detail:Alprazolam (Alprazolam)

Drug Class: Benzodiazepines

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Anxiety

Immediate-release tablets/orally disintegrating tablets (ODT): 0.25 to 0.5 mg orally administered 3 times a day

  • Maximum dose: 4 mg/day

Comments:
  • The lowest possible effective dose should be administered and the need for continued treatment reassessed frequently.
  • Dosage should be reduced gradually when discontinuing therapy or when decreasing the daily dosage.
  • The daily dosage may be decreased by no more than 0.5 mg every 3 days; however, some patients may require an even slower dosage reduction.
  • The dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg per day.
  • The times of administration should be distributed as evenly as possible throughout the waking hours

Uses:
  • Treatment of generalized anxiety disorder
  • Management of anxiety disorder or APA DSM-III-R diagnosis of generalized anxiety disorder
  • Short-term relief of symptoms of anxiety

Usual Adult Dose for Panic Disorder

Immediate-release tablets/ODTs: 0.5 mg orally administered 3 times a day

  • Maximum dose: 10 mg/day

Extended-release tablets:
  • Initial dose: 0.5 to 1 mg orally once a day
  • Maintenance dose: 3 to 6 mg orally per day, preferably in the morning
  • Maximum dose: 10 mg/day

Comments:
  • The lowest possible effective dose should be administered and the need for continued treatment reassessed frequently.
  • Dosage should be reduced gradually when discontinuing therapy or when decreasing the daily dosage.
  • The daily dosage may be decreased by no more than 0.5 mg every 3 days; however, some patients may require an even slower dosage reduction.
  • The dose of extended-release tablets may be increased at intervals of 3 to 4 days in increments of no more than 1 mg per day.
  • The times of administration should be distributed as evenly as possible throughout the waking hours

Use: Treatment of panic disorder, with or without agoraphobia

Usual Geriatric Dose for Anxiety

Elderly or debilitated patients:
Immediate-release tablets/ODTs: 0.25 mg orally administered 2 or 3 times a day

Comments:

  • If side effects develop, the dose may be lowered.
  • The lowest possible effective dose should be administered and the need for continued treatment reassessed frequently.
  • Dosage should be reduced gradually when discontinuing therapy or when decreasing the daily dosage.

Uses:
  • Treatment of generalized anxiety disorder
  • Management of anxiety disorder
  • Short-term relief of symptoms of anxiety

Usual Geriatric Dose for Panic Disorder

Elderly or debilitated patients:
Immediate-release tablets/ODTs:

  • Initial dose: 0.25 mg orally administered 2 or 3 times a day

Extended-release tablets:
  • Initial dose: 0.5 mg orally once a day

Comments:
  • If side effects develop, the dose may be lowered.
  • The lowest possible effective dose should be administered and the need for continued treatment reassessed frequently.
  • Dosage should be reduced gradually when discontinuing therapy or when decreasing the daily dosage.

Use: Treatment of panic disorder, with or without agoraphobia

Renal Dose Adjustments

  • Impaired renal function: Use with caution

Liver Dose Adjustments

Immediate-release tablets/ODTs:

  • Mild to moderate liver dysfunction: Use with caution
  • Severe liver dysfunction: 0.25 mg orally 2 or 3 times a day

Extended-release tablets:
  • Mild to moderate liver dysfunction: Use with caution
  • Severe liver dysfunction: 0.5 mg orally once a day

Dose Adjustments

Patients with debilitating disease (e.g., severe pulmonary disease):
Immediate-release tablets/ODTs:

  • Initial dose: 0.25 mg orally 2 or 3 times a day

Extended-release tablets:
  • Initial dose: 0.5 mg orally once a day

Switching Between Immediate and Extended-release Formulations:
  • Patients who are currently being treated with divided doses of immediate-release tablets, for example 3 to 4 times a day, may be switched to extended-release tablets at the same total daily dose taken once a day.

Dose Reduction:
Immediate-release tablets/ODTs:
  • Extended-release tablets: Doses should be decreased gradually, with dose decreases of no more than 0.5 mg every 3 days.

Precautions

US BOXED WARNINGS:
RISK FROM CONCOMITANT USE WITH OPIOIDS:

  • Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death.
  • Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate.
  • Limit dosages and durations to the minimum required.
  • Follow patients for signs/symptoms of respiratory depression and sedation.

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

US Controlled Substance: Schedule IV

Dialysis

Data not available

Other Comments

Administration advice:

  • Extended-release Tablets: Tablets should not be chewed, crushed, or broken.
  • ODTs:
  • Immediately upon opening the blister, using dry hands, remove the tablet and place it on top of the tongue.
  • Tablet disintegration occurs rapidly in saliva so it can be easily swallowed with or without water.

Storage requirements:
  • ODTs: Protect from light and moisture.
  • Oral solution: Protect from light; discard 90 days after opening.
  • Tablets: Protect from light.

General:
  • This drug is not recommended for the primary treatment of depression and psychotic illness.

Monitoring:
  • Genitourinary: Periodic urinalysis
  • Hematologic: Periodic blood counts during long-term treatment (e.g., longer than 4 weeks)
  • Hepatic: Periodic liver function tests during long-term treatment (e.g., longer than 4 weeks)
  • Metabolic: Periodic blood chemistry analyses

Patient advice:
  • This medicine may increase the risk of suicidal thoughts and behavior. Patients should be alert for the emergence or worsening of symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Patients should report any behavior of concern to their healthcare provider as soon as possible.
  • This drug may cause drowsiness and dizziness and reduce alertness. Patients should not drive a car or operate dangerous machinery until they know how this drug affects them.
  • Patients should avoid drinking alcohol or taking other drugs that may cause sleepiness or dizziness while taking this drug until they talk to their healthcare provider.
  • Patients should be told to contact their healthcare provider before increasing/decreasing the dose or discontinuing treatment.
  • Advise patients to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.

Frequently asked questions

  • How long does Xanax last for / stay in your system?
  • Klonopin vs Xanax - How are they different?
  • Ativan vs Xanax - What is the difference?
  • What is Farmapram called in the US?
  • What is Ksalol used for?
  • What is the half-life of a drug?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by